JPRN-UMIN000006898
Not yet recruiting
未知
Hypoxia imaging in lung cancer patients utilizing62Cu-ATSM-PET/CT with reference to histopathology. - Hypoxia imaging in lung cancer patients utilizing62Cu-ATSM-PET/CT with reference to histopathology.
Conditionslung cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- lung cancer
- Sponsor
- School of Medicine, Keio University
- Enrollment
- 30
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) The case who is difficult to be included in the study due to psychological disorder and so on. 2\) The case to whom the test agent cannot be injected due to iodine allergy and so on. 3\) The case who is judged by the physician in charge not to be included in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Hypoxia imaging in lung cancer patients utilizing(18F)FAZA-PET/CT with reference to histopathology.lung cancerJPRN-UMIN000004558Division of General Thoracic Surgery, School of Medicine, Keio University30
Completed
Not Applicable
Prospective study; Hypoxia imaging in lung cancer patients utilizing (18F)FAZA-PET/CT and 62Cu-ATSM PET/CT with reference to histopathology.ung cancerJPRN-UMIN000015413Division of General Thoracic Surgery, School of Medicine, Keio University30
Not yet recruiting
Phase 2
Validation of hypoxia imaging of cancer in the head and neck area with FAZA-PETNL-OMON32369Antoni van Leeuwenhoek Ziekenhuis20
Active, not recruiting
Not Applicable
18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung CancerLung CancerNCT02701699University Health Network, Toronto36
Active, not recruiting
Phase 1
Imaging of tumor hypoxia with [18F]HX4 PETEUCTR2014-003873-41-NLMAASTRO Clinic100